Search
for
Sort by
Research 571–600 of 1000+
- Skin manifestations associated with COVID-19
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Anticonvulsant-Induced Cutaneous Reactions
- The use of complementary and alternative medicine among dermatology outpatients in Eastern Turkey
- Topical nitrogen mustard in the treatment of alopecia areata: a bilateral comparison study
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Efficacy of Korean Red Ginseng in the Treatment of Atopic Dermatitis
- Vitamin D and the Skin: A Review for Dermatologists
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Nanocarrier Systems for Transdermal Drug Delivery
- The journey of patients with skin diseases from the first consultation to the diagnosis in a representative sample of the European general population from the EADV burden of skin diseases study
- Nocebo effect in Dermatology
- The Fate of Epidermal Tight Junctions in the stratum corneum: Their Involvement in the Regulation of Desquamation and Phenotypic Expression of Certain Skin Conditions
- Skin manifestations associated with systemic diseases – Part I
- Cutaneuos findings in patients with predialysis chronic kidney disease
- ‘Dr. Google, What Is That on My Skin?’—Internet Searches Related to Skin Problems: Google Trends Data from 2004 to 2019
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future
- Erosive pustular dermatosis of the scalp following topical ingenol mebutate for actinic keratoses
- Evaluation of a topical treatment for the relief of sensitive skin
- A single center, pilot, double-blinded, randomized, comparative, prospective clinical study to evaluate improvements in the structure and function of facial skin with tazarotene 0.1% cream alone and in combination with GliSODin® Skin Nutrients Advanced A
- Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
- Epidermal PPARγ Is a Key Homeostatic Regulator of Cutaneous Inflammation and Barrier Function in Mouse Skin
- Cancer risk by the subtype of alopecia
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Non‐Facial Skin Rejuvenation of the Neck, Chest, and Hands. Part One: Using Injections
- The Role of PGC-1α in Aging Skin Barrier Function
- Skin cancers and their risk factors in older persons: a population-based study
- Approach to Patients with Suspected Rheumatic Disease
- Transcriptomics analysis reveals molecular alterations underpinning spaceflight dermatology